Jeff Jones
Stock Analyst at Oppenheimer
(0)
# 4845
Out of 5,370 analysts
110
Total ratings
22.67%
Success rate
-20.29%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
YMAB Y-mAbs Therapeutics | Maintains: Outperform | 20 15 | 4.91 | 205.5% | 3 | May 29, 2025 | |
CMMB Chemomab Therapeutic... | Maintains: Outperform | 11 10 | 1.23 | 713.01% | 8 | May 16, 2025 | |
ALMS Alumis | Maintains: Outperform | 26 25 | 3.13 | 698.72% | 2 | May 15, 2025 | |
ZURA Zura Bio | Maintains: Outperform | 19 17 | 1.2 | 1316.67% | 4 | May 9, 2025 | |
CRVS Corvus Pharma | Reiterates: Outperform | 15 17 | 4.23 | 301.89% | 5 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 85 86 | 32.63 | 163.56% | 2 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 60 56 | 8.68 | 545.16% | 9 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 28 18 | 8.17 | 120.32% | 4 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 5 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 22 16 | 3.62 | 341.99% | 7 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 10 9 | 2.54 | 254.33% | 10 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 52 56 | 46.85 | 19.53% | 4 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 35 39 | 25.44 | 53.3% | 2 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 48 45 | 1.34 | 3258.21% | 6 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 4 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Perform | n/a | n/a | n/a | 3 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 32 30 | n/a | n/a | 3 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 13 15 | n/a | n/a | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 1920 | n/a | n/a | 3 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 13 | n/a | n/a | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 15 | 1.07 | 1301.87% | 5 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 75 | 0.68 | 10929.41% | 2 | Mar 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 125 150 | n/a | n/a | 6 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 1600 1100 | 2.4 | 45733.33% | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 193 | n/a | n/a | 1 | Jul 18, 2022 |